David E. Griffith
Impact in
- Small Animals top 0.01%
- Infectious Diseases and Mycology
- Microbiology top 0.1%
Papers in
- Epidemiology 155
- Mycobacterium research and diagnosis 144
- Pneumocystis jirovecii pneumonia detection and treatment 10
-
- Tuberculosis Research and Epidemiology 100
- Co-authors
- Richard J. Wallace (50 shared papers)Barbara A. Brown‐Elliott (34 shared papers)Charles L. Daley (26 shared papers)Timothy R. Aksamit (25 shared papers)Barbara Ann Brown (16 shared papers)Kevin L. Winthrop (26 shared papers)Kenneth N. Olivier (11 shared papers)Stephen J. Ruoss (9 shared papers)
- Journals
- CHEST Journal (26 papers)Clinical Infectious Diseases (20 papers)American Journal of Respiratory and Critical Care Medicine (18 papers)European Respiratory Journal (8 papers)Annals of the American Thoracic Society (8 papers)
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
David E. Griffith
203 papers receiving 16.0k citations
David E. Griffith's Hit Papers
Peers
Comparison fields: 5 of 147
- Small Animals 4.7k
- Microbiology 371
- Epidemiology 13.3k
- Infectious Diseases 7.3k
- Molecular Medicine 468
Countries citing papers authored by David E. Griffith
This map shows the geographic impact of David E. Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Griffith more than expected).
Fields of papers citing papers by David E. Griffith
This network shows the impact of papers produced by David E. Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Griffith. The network helps show where David E. Griffith may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Griffith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 208 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases Hit paper breakdown → | 2007 | 4831 |
| 2 | Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Hit paper breakdown → | 2020 | 601 |
| 3 | Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Hit paper breakdown → | 2020 | 594 |
| 4 | Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Hit paper breakdown → | 2020 | 573 |
| 5 | 1992 | 440 | |
| 6 | Clinical Features of Pulmonary Disease Caused by Rapidly Growing Mycobacteria: An Analysis of 154 Patients Hit paper breakdown → | 1993 | 435 |
| 7 | 1998 | 356 | |
| 8 | Adult Patients With Bronchiectasis Hit paper breakdown → | 2016 | 340 |
| 9 | 2006 | 297 | |
| 10 | 2014 | 292 | |
| 11 | Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study Hit paper breakdown → | 2018 | 271 |
| 12 | 1996 | 224 | |
| 13 | 2016 | 215 | |
| 14 | 2018 | 215 | |
| 15 | 2019 | 214 | |
| 16 | 2015 | 188 | |
| 17 | 2016 | 185 | |
| 18 | 2005 | 175 | |
| 19 | 1994 | 164 | |
| 20 | 2014 | 162 |
About David E. Griffith
David E. Griffith is a scholar working on Epidemiology, Infectious Diseases, Small Animals, Pulmonary and Respiratory Medicine and Organic Chemistry, having authored 208 papers that have together received 16.8k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (144 papers), Tuberculosis Research and Epidemiology (100 papers), Infectious Diseases and Mycology (52 papers), Infectious Diseases and Tuberculosis (13 papers), Quinazolinone synthesis and applications (13 papers), Cystic Fibrosis Research Advances (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Occupational and environmental lung diseases (8 papers). The work is most often cited by research in Small Animals (4.7k citations), Microbiology (371 citations), Epidemiology (13.3k citations), Infectious Diseases (7.3k citations) and Molecular Medicine (468 citations). David E. Griffith has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Richard J. Wallace, Barbara A. Brown‐Elliott, Charles L. Daley, Timothy R. Aksamit, Barbara Ann Brown, Kevin L. Winthrop, Kenneth N. Olivier, Stephen J. Ruoss, Antonino Catanzaro and Charles Fordham von Reyn. Their work appears in journals such as CHEST Journal, Clinical Infectious Diseases, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Annals of the American Thoracic Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.